Page last updated: 2024-10-21

menthol and Kahler Disease

menthol has been researched along with Kahler Disease in 2 studies

Menthol: A monoterpene cyclohexanol produced from mint oils.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Colvin, LA1
Johnson, PR1
Mitchell, R1
Fleetwood-Walker, SM1
Fallon, M1
Sidell, N1
Taga, T1
Hirano, T1
Kishimoto, T1
Saxon, A1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency Syndromes[NCT00001438]Phase 230 participants Interventional1995-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for menthol and Kahler Disease

ArticleYear
From bench to bedside: a case of rapid reversal of bortezomib-induced neuropathic pain by the TRPM8 activator, menthol.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Sep-20, Volume: 26, Issue:27

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Boronic Acids; Borte

2008
Retinoic acid-induced growth inhibition of a human myeloma cell line via down-regulation of IL-6 receptors.
    Journal of immunology (Baltimore, Md. : 1950), 1991, Jun-01, Volume: 146, Issue:11

    Topics: Cell Division; Down-Regulation; Humans; Interleukin-6; Menthol; Multiple Myeloma; Receptors, Immunol

1991